Description

Ethyl Methyl 4,4'-(3-Methyl-6-Oxo-2,6-Dihydropyrrolo[3,4-C]Pyrazole-4,5(4H)-Diyl)Dibenzoate is a high-purity, advanced pharmaceutical intermediate with a complex heterocyclic structure. This compound is of significant value for its role as a key building block in the synthesis of novel active pharmaceutical ingredients (APIs), particularly in therapeutic areas requiring sophisticated molecular scaffolds. It is primarily needed by research institutions and pharmaceutical manufacturers engaged in the development of new drugs, especially within oncology and central nervous system (CNS) research.

Application

• Pharmaceutical Intermediate: A critical precursor in the multi-step synthesis of novel drug candidates and target molecules.
• Research & Development (R&D): Used in medicinal chemistry for structure-activity relationship (SAR) studies and lead optimization.
• API Synthesis: Serves as a core scaffold for constructing complex molecules with potential biological activity.
• Chemical Biology: Employed in the development of chemical probes for studying biological pathways and target validation.
• Contract Manufacturing (CMO): Supplied to organizations specializing in the custom synthesis of complex organic compounds for clinical trials.
• Academic Research: Utilized in university and institutional labs for pioneering synthetic methodology and novel compound library generation.

Basic Information

Product Name	Ethyl Methyl 4,4'-(3-Methyl-6-Oxo-2,6-Dihydropyrrolo[3,4-C]Pyrazole-4,5(4H)-Diyl)Dibenzoate
CAS No.	840517-30-8
Molecular Formula	C25H23N3O5
Molecular Weight	445.47 g/mol
Synonyms	4,5-Dihydro-4,5-[4,4'-(ethyl methyl dibenzoate)]-3-methyl-6H-pyrrolo[3,4-c]pyrazol-6-one; Ethyl Methyl 4,4'-(3-Methyl-6-oxo-4,5,6-trihydropyrrolo[3,4-c]pyrazole-4,5-diyl)dibenzoate; 840517-30-8; Pyrrolopyrazole-dibenzoate derivative; EMDP Intermediate; 3-Methyl-4,5-bis(4-(methoxycarbonyl)phenyl)-4,5-dihydro-1H-pyrrolo[3,4-c]pyrazol-6(2H)-one ethyl ester analog (mixed ester).
EINECS	Contact for details

Quality Control

Our Ethyl Methyl 4,4'-(3-Methyl-6-Oxo-2,6-Dihydropyrrolo[3,4-C]Pyrazole-4,5(4H)-Diyl)Dibenzoate is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation, to ensure it meets the high standards required for pharmaceutical R&D. A comprehensive Certificate of Analysis (COA) detailing purity, related substances, and other critical parameters is provided with every shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). This product is hygroscopic (moisture-sensitive) and should be handled in a dry environment to prevent degradation. For long-term storage, consider desiccant or inert atmosphere conditions.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Conforms to reference
Purity (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0%
Single Maximum Unknown Impurity	≤ 0.5%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.